Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KP-607 nail concentration study in onychomycosis (Phase I)
jRCT2080224040Phase 1Completed
- Sponsor
- KAKEN PHARMACEUTICAL CO., LTD.
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of KP-607 in onychomycosis (2 arms), sponsored by KAKEN PHARMACEUTICAL CO., LTD. Started Sep 2018; status: completed.
02
Drugs
KP-607
03
Conditions
onychomycosis
Beyond the preview
Go deeper on jRCT2080224040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224040.